131 related articles for article (PubMed ID: 37976515)
41. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
42. Improving Indirect Revascularization for Effective Treatment of Adult Moyamoya Disease: A Prospective Clinical, Cerebral Angiographic, and Perfusion Study.
Chou SC; Chen YF; Lee CW; Hsu HC; Wang KC; Yang SH; Liu HM; Kuo MF
World Neurosurg; 2018 Nov; 119():e180-e191. PubMed ID: 30031192
[TBL] [Abstract][Full Text] [Related]
43. Long-term Outcome After Multiple Burr Hole Surgery in Children With Moyamoya Angiopathy: A Single-Center Experience in 108 Hemispheres.
Blauwblomme T; Mathon B; Naggara O; Kossorotoff M; Bourgeois M; Puget S; Meyer P; Brousse V; de Montalembert M; Brunelle F; Zerah M; Sainte-Rose C
Neurosurgery; 2017 Jun; 80(6):950-956. PubMed ID: 28327981
[TBL] [Abstract][Full Text] [Related]
44. Direct Versus Indirect Revascularization for Moyamoya: a Large Multicenter Study.
El Naamani K; Chen CJ; Jabre R; Saad H; Grossberg JA; Dmytriw AA; Patel AB; Khorasanizadeh M; Ogilvy CS; Thomas A; Monteiro A; Siddiqui A; Cortez GM; Hanel RA; Porto G; Spiotta AM; Piscopo AJ; Hasan DM; Ghorbani M; Weinberg J; Nimjee SM; Bekelis K; Salem MM; Burkhardt JK; Zetchi A; Matouk C; Howard BM; Lai R; Du R; Abbas R; Sioutas GS; Amllay A; Munoz A; Atallah E; Herial NA; Tjoumakaris SI; Gooch MR; Rosenwasser RH; Jabbour P
J Neurol Neurosurg Psychiatry; 2024 Feb; 95(3):256-263. PubMed ID: 37673641
[TBL] [Abstract][Full Text] [Related]
45. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease.
Hamano E; Kataoka H; Morita N; Maruyama D; Satow T; Iihara K; Takahashi JC
J Neurosurg; 2017 Jan; 126(1):1-7. PubMed ID: 26894456
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.
Fujimura M; Inoue T; Shimizu H; Saito A; Mugikura S; Tominaga T
Cerebrovasc Dis; 2012; 33(5):436-45. PubMed ID: 22456617
[TBL] [Abstract][Full Text] [Related]
47. Hyperperfusion syndrome after superficial temporal artery-middle cerebral artery bypass for non-moyamoya steno-occlusive disease.
Turpin J; Lynch DG; White T; Shah KA; Yang K; Katz JM; Dehdashti AR
J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107222. PubMed ID: 37384979
[TBL] [Abstract][Full Text] [Related]
48. Moyamoya disease: Experience with direct and indirect revascularization in 70 patients from a nonendemic region.
Sadashiva N; Reddy YV; Arima A; Saini J; Shukla D; Pandey P
Neurol India; 2016; 64 Suppl():S78-86. PubMed ID: 26954973
[TBL] [Abstract][Full Text] [Related]
49. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
50. Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study.
Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Ye X; Liu X; Zhang Q; Wang J; Yang Z; Zhao M; Zhao J
J Neurosurg; 2018 May; 128(5):1327-1337. PubMed ID: 28686113
[TBL] [Abstract][Full Text] [Related]
51. Adolescents with moyamoya disease: clinical features, surgical treatment and long-term outcomes.
Zhao M; Zhang D; Wang S; Zhang Y; Wang R; Deng X; Gao F; Zhao J
Acta Neurochir (Wien); 2017 Nov; 159(11):2071-2080. PubMed ID: 28791519
[TBL] [Abstract][Full Text] [Related]
52. Revascularization of Moyamoya Angiopathy in Older Adults.
Williamson RW; Abla AA; Zabramski JM; Nakaji P; Spetzler RF; Wanebo JE
World Neurosurg; 2017 Mar; 99():37-40. PubMed ID: 27890765
[TBL] [Abstract][Full Text] [Related]
53. Risk profile in extracranial/intracranial bypass surgery--the role of antiplatelet agents, disease pathology, and surgical technique in 168 direct revascularization procedures.
Schubert GA; Biermann P; Weiss C; Seiz M; Vajkoczy P; Schmiedek P; Thomé C
World Neurosurg; 2014 Nov; 82(5):672-7. PubMed ID: 23838364
[TBL] [Abstract][Full Text] [Related]
54. Predictors and clinical features of transient neurological events after combined bypass revascularization for moyamoya disease.
Lu J; Zhao Y; Ma L; Chen Y; Li M; Chen X; Ye X; Wang R; Zhao Y
Clin Neurol Neurosurg; 2019 Nov; 186():105505. PubMed ID: 31622898
[TBL] [Abstract][Full Text] [Related]
55. Surgical revascularization as a procedure to prevent neurological complications in children with moyamoya syndrome associated with neurofibromatosis I: a single institution case series.
Morello A; Scala M; Schiavetti I; Diana MC; Severino M; Tortora D; Piatelli G; Pavanello M
Childs Nerv Syst; 2024 Jun; 40(6):1731-1741. PubMed ID: 38316674
[TBL] [Abstract][Full Text] [Related]
56. Short- and long-term outcomes of moyamoya patients post-revascularization.
Teo M; Abhinav K; Bell-Stephens TE; Madhugiri VS; Sussman ES; Azad TD; Ali R; Esparza R; Zhang M; Steinberg GK
J Neurosurg; 2023 May; 138(5):1374-1384. PubMed ID: 36272120
[TBL] [Abstract][Full Text] [Related]
57. Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age.
Bot GM; Burkhardt JK; Gupta N; Lawton MT
J Neurosurg Pediatr; 2018 Nov; 23(2):198-203. PubMed ID: 30497164
[TBL] [Abstract][Full Text] [Related]
58. Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres.
Fujimura M; Tominaga T
Neurol Med Chir (Tokyo); 2012; 52(5):327-32. PubMed ID: 22688070
[TBL] [Abstract][Full Text] [Related]
59. Postoperative neovascularization, cerebral hemodynamics, and clinical prognosis between combined and indirect bypass revascularization procedures in hemorrhagic moyamoya disease.
Sun J; Li ZY; Chen C; Ling C; Li H; Wang H
Clin Neurol Neurosurg; 2021 Sep; 208():106869. PubMed ID: 34419781
[TBL] [Abstract][Full Text] [Related]
60. Practice variability in the perioperative management of pediatric moyamoya disease in North America.
Sun LR; Hersh DS; Smith ER; Aldana PR; Jordan LC
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107029. PubMed ID: 36706654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
